The Utility of the Liverpool Adverse Drug Reaction Assessment Tools in the Evaluation of Chemotherapy-Induced Nausea and Vomiting in Children

Lima, Elisangela Costa; Fernandes, Thais de Barros; Land, Marcelo Gerardin Poirot; Gonzalez, Caio; Thorbinson, Colin; Bains, Caroline; Bracken, Louise E; Peak, Matthew; Pizer, Barry.
Rev. Bras. Cancerol. (Online) ; 69(3)jul-set. 2023.
Artículo en Inglés | LILACS, SES-SP | ID: biblio-1512587

Documentos relacionados

  1. Effect of ginger and P6 acupressure on chemotherapy-induced nausea and vomiting: a randomized controlled study
  2. Optimizing antiemetic therapy for children undergoing chemotherapy.
  3. Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy-induced nausea and vomiting management: Experiences at an academic medical center.
  4. Palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting in pediatric patients: a meta-analysis.
  5. Evaluation of chemotherapy-induced nausea and vomiting in pediatric patients with high-grade glioma treated with lomustine-a case series.
  6. Addressing adherence to guidelines on prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients.
  7. Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review.
  8. The emerging emetogenicity of trifluridine/tipiracil (TAS­102) from patient self-reporting: a multicenter, prospective, observational study.
  9. Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting.
  10. Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association study.